Neoleukin Therapeutics, Inc. (NLTX) NASDAQ
3.49
+0.05(+1.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 73.88M |
| Enterprise Value | -20.08M |
| P/E Ratio | -0.79 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.37 |
| Return On Equity | -0.38 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -103.33M |
| Net Income | -90.35M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 243.18M |
| Total Cash/Share | 10.9 |
| Total Debt | 9.13M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 13.08 |
| Book Value Per Share | 10.66 |
Price History
| 52-Week Change | -69.39 |
| 52-Week High | 18.8 |
| 52-Week Low | 3.42 |
| Moving Average 50 Days | 13.83 |
| Moving Average 200 Days | 14.98 |
Statistics
| Average Volume | 5,520 |
| Shares Outstanding | 2.35M |
| % Held by Institutions | 31.4 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | December 19, 2023 |
